tirzepatide discontinuation weight regain study after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial GLP-1 discontinuation: weight-loss drugs work

Based on this finding, the most recent 2018 recommendations from the American Diabetes Association state that compared with basal-plus insulin, basal insulin plus GLP-1 RAs are associated with less hypoglycemia and with weight loss instead of weight gain but may be less tolerable and have a greater cost [2]

The combination works by addressing underlying healing deficits rather than just masking symptoms

Untersttzung der Hautbarriere Eine intakte Hautbarriere hlt Feuchtigkeit in der Haut und schtzt vor ueren Reizen

Both medications are effective, but tirzepatides dual mechanism (targeting both GIP and GLP-1 receptors) appears to provide an edge